Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Regeneron Pharmaceuticals, Inc.

REGN ✓ COMPLIANTFree checks used up today ☆ Track — members
NASDAQ · Healthcare · Pharmaceuticals ·
USA Large Cap Analyst: BUY
Last Close
$789.45
▲ +1.92%
Market Cap $81.28B · Vol 303.99K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
19.32
FWD: 13.17
Market Cap
$81.28B
Large Cap
Div Yield
0.49%
Quarterly dividend
EPS Growth
+24.12%
YoY
RSI (14)
45.17
Momentum
Beta
0.15
vs Market
52W High
$858.01
9.72% below
52W Low
$541.00
43.18% above
Volume
303.99K
Avg 240.57K
P/B
2.61
Price-to-book
ROE
16.13%
Return on equity
Free Float
97.85%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, Regeneron Pharmaceuticals, Inc. (REGN) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does REGN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
-0.48%
1M
-2.04%
3M
+29.86%
6M
+4.01%
YTD
+2.28%
1Y
+34.83%
3Y
-4.12%
5Y
+21.10%
Financials & Valuation
TTM · Annual
Total Revenue$14.34B
Net Income$4.55B
Revenue Growth (YoY)+16.73%
Gross Margin86.56%
Operating Margin27.02%
Net Profit Margin31.72%
ROE16.13%
ROA · ROIC13.36% · 13.76%
P/E Ratio19.32
Forward P/E (FY1)13.17
PEG Ratio1.99
P/S5.84
P/B2.61
P/FCF22.26
EPS Growth+24.12%
Outstanding Shares102.95M
Technical Indicators
50-Day SMA$761.23
200-Day SMA$733.62
RSI (14)45.17
Beta0.15
52-Week High$858.01
52-Week Low$541.00
Volume Today303.99K
Avg Daily Volume (30D)240.57K
Relative Volume1.26x
Volatility (10D)22.99
Volatility (30D)27.34
Free Float97.85%
AAOIFI Certified Shariah Advisor and Auditor certificate